Endoscopic Laser Bioprinting for Cartilage Regeneration
3rd Call for H.F.R.I.’s Research Projects to Support Faculty Members & Researchers Learn MoreCARDILAS develops cutting-edge endoscopic laser bioprinting technology for minimally invasive cartilage regeneration using Laser-Induced Forward Transfer (LIFT).
Read moreDevelop and validate an integrated endoscopic laser bioprinting system for in-situ bioprinting of cells for cartilage regeneration with high precision and cell viability.
Read moreRevolutionize cartilage repair treatments with minimally invasive procedures, reducing patient recovery time and improving clinical outcomes.
Read moreCARDILAS (Cartilage Regeneration via Direct Intra-articular Laser-Assisted Bioprinting System) is an innovative research project that aims to develop a groundbreaking endoscopic laser bioprinting platform for the regeneration of articular cartilage.
The project leverages advanced Laser-Induced Forward Transfer (LIFT) technology to enable precise, minimally invasive printing of cell-laden Bioinks with Mesenchymal Stem Cells (MSCs) and appropriate growth factors directly onto damaged cartilage surfaces within the joint environment.
By combining state-of-the-art laser technology with novel biomaterials and endoscopic instrumentation, CARDILAS seeks to transform the treatment paradigm for osteoarthritis and cartilage injuries, offering patients a less invasive alternative to traditional surgical interventions.
The CARDILAS project pursues ambitious scientific goals to advance the field of regenerative medicine:
CARDILAS employs cutting-edge technologies and innovative approaches to achieve its groundbreaking objectives.
High-precision laser printing technique enabling cell printing with micrometer-level accuracy and selective deposition of cell-laden bioinks.
Novel optical fiber delivery system and miniaturized printing head designed for seamless integration with arthroscopic surgical platforms.
Development of specialized hydrogel formulations optimized for laser printing, cell encapsulation, and integration with native cartilage tissue.
CARDILAS is poised to deliver significant scientific, clinical, and societal impacts: